Back to search

Peptide record

TPDB92243

P18 Antibacterial Anticancer Toxicity standard
17 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB92243
P18
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
dbAMP Peptipedia AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF pep-lab
standard
No
A 17-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from dbAMP, Peptipedia, AntiCP 2.0, and other sources, with an available 3D structural model.
C-terminal: Amidation
Sequence
KWKFKKIPKFLHLAKKF-NH2
Physicochemical Analysis
C112H175N27O18
RNDCEQGMSTYV
K
2187.79
11.29
8
0
8
+7
1.50
-0.629
74.71
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
5500
251.40
0
Residue Composition
number
1
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
1
H
1
I
2
L
7
K
0
M
3
F
1
P
0
S
0
T
1
W
0
Y
0
V
Amino Acid Distribution
A: 1 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 1 I: 1 L: 2 K: 7 M: 0 F: 3 P: 1 S: 0 T: 0 W: 1 Y: 0 V: 0
Chemical Descriptors
17
C112H175N27O18
2187.79
11.29
+7
1.50
-0.629
Amidation
L
Linear
Free
Antibacterial
Ceropin A
Evidence Records 3 records
Evidence 1 Activity

Activity

IC50
IC50=8 µM
Anticancer
8 µM

Target

Breast Cancer
MDA-MB-361
Breast

Assay & Model

MTT/MTS assay
48-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2001

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50=4 µM
Anticancer
4 µM

Target

Blood Cancer
Jurkat
Blood

Assay & Model

MTT/MTS assay
48-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2001
Evidence 3 Activity

Activity

IC50
IC50=3.5 µM
Anticancer
3.5 µM

Target

Leukemia Cancer
K-562
Blood

Assay & Model

MTT/MTS assay
48-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2001